Cardiothoracic & vascular anesthesia

Dexmedetomidine improves pulmonary outcomes in thoracic surgery under one-lung ventilation: A meta-analysis

J Clin AnesthPublished Systematic review and meta-analysis of randomised trials

Pooled result · Low certaintyResult — go to the resultOdds ratio 0.42 95% CI 0.18–0.95

Authors' conclusion

Dexmedetomidine administration during thoracic surgery may potentially reduce the risk of postoperative atelectasis and hypoxemia.

Study context

Population
Patients undergoing thoracic surgery under one-lung ventilation (OLV)12 RCTs
Participants
365 vs 359
Comparison
Dexmedetomidine vs placebo during thoracic surgery
  • Dexmedetomidinen = 365
  • Placebon = 359reference
Outcome
Atelectasis
Follow-up
Within 7 days after surgery
Methodological detailsrandom effects models
  • Random effects models

Pooled result

Low certainty

Odds ratio

0.42

95% CI 0.18–0.95

P = 0.04

By group

Dexmedetomidine vs Placebo
OR 0.42 (95% CI 0.18–0.95); P = 0.04

As reported in the abstract

Further pooled results

OutcomeDexmedetomidinePlaceboOR (95% CI)P value
Postoperative hypoxemiaModerate certainty3.4%11.7%0.26 (0.10–0.68)P = 0.01
OutcomeMean difference (mL/cmH2O) (95% CI)
Intraoperative respiratory compliance (Cdyn)4.42 (3.13–5.72)
OutcomeMean difference (L) (95% CI)
Postoperative FEV10.27 (0.12–0.41)

Postoperative pneumonia

OR
0.57 (95%CI 0.25-1.26, P = 0.17)
Incidence comparable between groups (3.2% vs 5.8%)
  • Moderate certainty

Postoperative acute respiratory distress syndrome (ARDS)

OR
0.39 (95%CI 0.07-2.08, P = 0.27)
Incidence comparable between groups (0.9% vs 3.5%)
  • Moderate certainty

Original publication

Dexmedetomidine improves pulmonary outcomes in thoracic surgery under one-lung ventilation: A meta-analysis. J Clin Anesth. Published 20 November 2023. doi:10.1016/j.jclinane.2023.111345

Composed by AI from the published abstract and checked against it. How Briefs are made →

Get them every week

New studies on this topic in My Week and in your Monday e-mail.

We e-mail you a sign-in link and a code. No password, no spam.